Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Skin and mucous membrane issues are common in kids after bone marrow transplants, so careful monitoring is crucial.

Combined prednisone and cyclosporine therapy led to excellent hair regrowth and improved well-being.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

A rare case of a transplant patient developing a skin condition linked to HPV-49.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Pulsed electric field treatment may help the immune system fight liver tumors.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

A kidney transplant and immunosuppressive treatment stopped the skin disease in a patient.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Early recognition and treatment of VATS in transplant patients improve outcomes.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.